BCL2 and colorectal cancer: We have discovered that the combination of a Wnt inhibitor (PP/PPh) with a Bcl-2-family inhibitor (ABT263) is effective in killing colorectal cancer cells with APC mutations both in vitro and in colon tumor xenografts (27).